Penile intraepithelial neoplasia incidence, clinical classification, microenvironment and implications for imiquimod treatment
- 19 July 2024
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 134 (6) , 881-889
Abstract
Objectives: To provide an outline of the existing data on penile intraepithelial neoplasia (PeIN), as well as a narrative review on imiquimod (IQ; a toll‐like receptor 7 agonist) treatment and immune microenvironment markers that may predict response to treatment. Methods: A narrative review of the literature from 2000 to the present was conducted on PubMed, and we describe the most relevant data and cross references. Results: The incidence of PeIN is increasing. Local therapy with IQ may offer an easy applicable treatment with complete response rates of up to 63% but can be associated with considerable side‐effects. There is no conclusive data on the optimal treatment schedule for PeIN, but evaluation of treatment results for other human papillomavirus‐related pre‐malignancies suggest three times a week for a duration up to 16 weeks. There are no published studies concerning the PeIN immune microenvironment. However, findings from the few studies on penile cancer and pre‐cancerous vulvar and cervical lesions imply that specific immune cell subpopulations can serve as future predictors for successful immunomodulation treatments such as IQ. Conclusions: Overall, limited data are available on IQ treatment for PeIN and no published data exists on the PeIN immune microenvironment. Further translational studies are warranted to gain more understanding on the pathophysiology of PeIN and potential predictors of progression and of response to topical treatments.Keywords
This publication has 51 references indexed in Scilit:
- European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 UpdateEuropean Urology, 2023
- Incidence of penile intraepithelial neoplasia and incidence and survival of penile cancer in Denmark, 1997 to 2018Cancer Causes & Control, 2021
- Topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) 2–3: A narrative reviewGynecologic Oncology Reports, 2020
- A pre‐existing coordinated inflammatory microenvironment is associated with complete response of vulvar high‐grade squamous intraepithelial lesions to different forms of immunotherapyInternational Journal of Cancer, 2020
- Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune toleranceBrain, Behavior, and Immunity, 2019
- Combination of imiquimod with cryotherapy in the treatment of penile intraepithelial neoplasiaJAAD Case Reports, 2017
- Treatment of Carcinoma In Situ of the Glans Penis With Topical Imiquimod Followed by Carbon Dioxide Laser ExcisionClinical Genitourinary Cancer, 2017
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular TumoursEuropean Urology, 2016
- Treatment of Carcinoma In Situ of the Glans Penis with Topical Chemotherapy AgentsEuropean Urology, 2012
- Distribution and characterization of subtypes of penile intraepithelial neoplasia and their association with invasive carcinomas: a pathological study of 139 lesions in 121 patientsHuman Pathology, 2012